Shanghai Haohai Biological Technology Co., Ltd. (stock code: 06826 on the Hong Kong Stock Exchange; 688366 on the Sci-tech Innovation Board) released a Next Day Disclosure Return dated 28 November 2025. According to the document, the total number of H shares remains at 38,529,240, with no changes recorded. The A shares stand at 190,203,760 and treasury shares at 3,848,095, resulting in a total of 194,051,855 shares.

From 15 September 2025 to 28 November 2025, multiple batches of H shares were repurchased but not yet cancelled. On 28 November 2025, 50,000 H shares were repurchased at HKD 27.67 per share, with an aggregate price paid of HKD 1,383,426. The company reported no change in A shares during this period.

The document indicates that the repurchases were conducted under a mandate approved on 10 June 2025, which authorized the repurchase of up to 3,914,184 shares. As of the disclosure date, 1,687,200 repurchased H shares were reported under this mandate, representing approximately 4.3105% of the issued shares (excluding treasury shares) at the time of the original authorization. A 30-day moratorium period for new share issuance or sale of treasury shares was noted to extend until 28 December 2025.